Clinical Trials · NCT01440803

Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Elizabeth Shane
Enrollment
41
Start date
Aug 2012
Locations
2 sites, United States
Primary endpoint
Change in Lumbar Spine Bone Mineral Density (LS-BMD) on Active Medication
View Teriparatide compound reference